Insulet Corporation

Healthcare · Medical Devices

135.30$ +0.6% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Income Statement

Insulet Corporation (PODD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 802 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PODD
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	95	104	102	110	122	131	124	124	151	165	160	177	192	209	198	226	234	246	252	263	276	308	295	299	341	370	358	397	433	510	442	489	544	598	569	649	706	784	762	802	3,054
Cost of Revenue	39	43	42	45	48	51	48	42	49	55	53	61	69	75	71	84	82	85	85	81	87	95	86	109	153	152	118	132	139	149	135	158	167	167	160	197	196	215	233	239	883
Gross Profit	56	61	59	65	74	80	76	82	102	110	107	116	123	134	127	143	152	161	168	183	189	213	210	190	188	217	241	265	293	361	307	331	377	431	409	452	510	569	529	563	2,170
Research & Development	14	16	18	18	20	19	20	18	22	29	32	32	31	35	36	34	39	38	41	40	38	42	43	43	45	50	50	55	58	42	50	54	55	61	60	73	77	91	90	88	346
Selling, General & Administrative	17	24	19	20	23	26	24	24	38	26	26	29	28	33	84	81	89	130	111	116	118	122	129	174	140	144	163	179	168	191	190	222	206	237	241	258	315	331	317	345	1,309
Total Operating Expenses	53	65	65	68	72	80	76	78	95	94	99	109	106	116	119	115	128	168	151	156	155	164	172	217	185	194	213	234	239	255	250	276	289	322	320	331	392	422	407	433	1,655
Operating Income	2.4	-4.1	-5.3	-3.4	2.0	-0.8	1.7	4.3	6.9	16	7.3	7.6	17	18	7.5	28	24	-7.3	16	26	34	50	38	-27	2.9	24	28	31	55	106	57	55	88	109	89	121	118	146	122	130	516
Interest Expense	3.0	5.1	5.0	4.8	4.7	6.2	7.9	7.3	6.8	5.3	6.6	5.7	9.4	9.1	12	12	12	13	14	17	16	15	9.0	9.1	9.2	9.2	9.4	9.7	10	6.7	11	11	12	8.7	9.2	20	16	20	15	14	63
Pre-Tax Income	-3.0	-9.0	-9.9	-7.7	-2.1	-6.9	-6.2	-1.3	1.9	11	4.7	1.9	1.1	6.8	-2.6	17	13	-19	0.3	-28	15	33	29	-36	-5.7	22	25	29	54	108	55	51	83	111	48	28	123	140	113	119	495
Income Tax Expense	0.1	0.2	0.1	0.1	0.1	-0.1	0.3	0.4	0.2	1.0	0.3	0.5	0.3	1.8	-0.5	3.0	1.8	-1.4	-0.3	-3.4	2.6	4.2	1.5	-1.1	-0.5	5.3	0.8	1.2	1.8	4.5	3.4	-138	5.4	11	13	5.9	35	39	22	24	119
Net Income	-3.1	-9.1	-10.0	-7.8	-2.2	-6.9	-6.6	-1.7	1.7	9.9	4.4	1.4	0.8	5.0	-2.1	14	12	-17	0.6	-25	13	29	28	-35	-5.2	17	24	27	52	103	52	189	78	101	35	23	88	102	91	95	375
EBITDA	3.7	-0.5	-1.6	0.5	6.4	3.1	5.2	9.0	12	22	16	15	18	26	17	38	36	19	26	2.4	45	63	53	-12	19	47	51	56	83	133	84	81	117	142	79	70	160	184	154	159	657

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings